Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
This target trial emulation study provides critical insights into weight change associated with eight first-line antidepressants, emphasizing the minimal weight gain with bupropion. Clinicians should integrate these findings into treatment decisions to address patient concerns about weight gain.
Endocrinology, Diabetes, Metabolism July 10th 2024
GoodRx Health
Clinicians should be vigilant about melatonin interactions with various medications such as antidepressants, blood thinners, and blood pressure drugs to ensure patient safety and effective treatment.
All Specialties July 10th 2024
The New England Journal of Medicine
In this NEJM Double Take episode, experts discuss the critical role of neuroplasticity in depression and examine advanced treatment options for patients who do not respond to traditional therapies. Topics include the efficacy of ECT and TMS, as well as emerging evidence for ketamine, esketamine, and psilocybin.
Psychiatry June 4th 2024
Psychiatry Advisor
Recent studies indicate that while ketamine and ECT are equally effective for treating MDD, ketamine did not prove non-inferior to ECT for MDEs. Both treatments have distinct side effect profiles that are critical for clinical decision-making.
Psychiatry May 21st 2024
MDLinx
Physicians must be vigilant of the impact that various medications can have on sexual function, including those less commonly associated with sexual side effects, to ensure holistic patient care and adherence to treatment.
All Specialties March 12th 2024
Consultant360
In this video, Dr. Charles Raison reveals how hyperthermia may harness the body’s immune response to combat major depressive disorder, suggesting a potential shift in non-pharmacological treatment strategies.
Psychiatry February 13th 2024